# Reduction of Bladder Injection Pain With Belladonna Opiate Suppository

> **NCT02600715** · PHASE4 · COMPLETED · sponsor: **Edgar LeClaire, MD** · enrollment: 26 (actual)

## Conditions studied

- Overactive Bladder
- Urinary Urge Incontinence
- Urinary Bladder, Neurogenic
- Painful Bladder Syndrome

## Interventions

- **DRUG:** Onabotulinumtoxin A (BoNT)
- **DRUG:** belladonna
- **DRUG:** Morphine
- **DRUG:** Placebo
- **DRUG:** Active B&O suppository of belladonna

## Key facts

- **NCT ID:** NCT02600715
- **Lead sponsor:** Edgar LeClaire, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-06-26
- **Final completion:** 2017-06-26
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2018-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02600715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02600715, "Reduction of Bladder Injection Pain With Belladonna Opiate Suppository". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02600715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*